Stock Events

Protalix BioTherapeutics (PLX) Q3 2023 Earnings

6NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.15
-0.03
0.09
0.21

Details

Expected EPS
-0.04
Actual EPS
-0.04
Surprise EPS
0
Surprise Percent
+0%

Description

Protalix BioTherapeutics (PLX) has reported earnings of -0.04 per share for Q3 2023.

0 Comments

Share your thoughts